The maximum permitted eight-hour time-weighted average concentration of an airborne contaminant. For Permissible Exposure Limits, see CFR 29 - 1910.1000.
Glossary
Permissible Exposure Limit (PEL)
02.27.12
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
-
Information Technology | Logistics | Packaging & Tracking | Promotions & Moves | Serialization
Adents Appoints Senior Director
Bronander to Lead North American expansion
-
APIs | Capsules | Cleaning Validation | Clinical Trials | Cytotoxics and High Potency Manufacturing | Risk Management | Validation
High Potency Re-Rebuttal
Let’s move forward, allowing good science to guide the way.Stephanie Wilkins, PharmaConsult Us
-
Breaking News | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Process Development
Quincy Bioscience Receives NSF GMP Recertification
Manufacturing methods in accordance with FDA’s 21 CFR part 111Kristin Brooks
-
Cleaning Validation | Clinical Trials | Cytotoxics and High Potency Manufacturing | GMPs/GCPs | Inspections | Laboratory Testing | Process Validation | Regulatory Affairs | Risk Management | Validation
High Potency Regulations
Uncertainty remains in the quest to define certain productsStephanie Wilkins, PharmaConsult US, Inc.
